Efficacy and safety of lopinavir/ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1

There are three classes of HIV-1 based on diversity of the viral envelope: M (major), O (outlying) and N (new). The M group is subclassified into nine major subtypes including A—D, F—H, J and K, as well as several recombinant forms. There is a growing need to evaluate antiretroviral (ARV) treatment in these diverse subtypes. Supplement Abstracts of the Tenth International Congress on Drug Therapy in HIV Infection http://www.biomedcentral.com/content/pdf/1758-2652-13-S4-info.pdf Conference Tenth International Congress on Drug Therapy in HIV Infection 7-11 November 2010 Glasgow, UK doi:10.1186/1758-2652-13-S4-P30 Cite this article as: Maroldo et al.: Efficacy and safety of lopinavir/ ritonavir (LPV/r) in antiretroviral-experienced subjects infected with different subtypes of HIV-1. Journal of the International AIDS Society 2010 13(Suppl 4):P30. Full text: PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113032/